Galileo (Clinics/Outpatient Services)

Clinics/Outpatient Services · New York, NY · Founded 2016 · Privately Held (backing)

Developer of a health assistance mobile application designed to make healthcare more effective and affordable. Galileo (Clinics/Outpatient Services) is based in New York, NY and was founded in 2016. It was valued at $362 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $210 million across 1 recorded round; the latest was a $60 million Series D in Dec 2022.

PMV mark · valuation
$361.5M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$209.9M
Last round
Later Stage VC (Series D)
Dec 2022
What is Galileo (Clinics/Outpatient Services) worth?
$361.5MPrivateMarketView mark · Oct 2026

Valued at $361.5M at its later-stage round, Jun 2025. Nothing has traded since.

Free account
More of Galileo (Clinics/Outpatient Services) with a free account
  • ·The complete investor list: 27 names
  • ·Watch Galileo (Clinics/Outpatient Services): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Galileo (Clinics/Outpatient Services) funding history

1 rounds
DateRoundRaisedPost-money
Dec 2022Later Stage VC (Series D)$60.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Galileo (Clinics/Outpatient Services) valuation

Galileo (Clinics/Outpatient Services) was valued at $362 million at its later-stage round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Galileo (Clinics/Outpatient Services) raised?

Galileo (Clinics/Outpatient Services) has raised $210 million in total; 1 of its rounds is on record. The largest on record was a $60 million Series D in Dec 2022.

Comparable companies

Comparable clinics/outpatient services names by valuation on PrivateMarketView: Nephrocare Health Services (NSE: NEPHROPLUS) ($515 million), Oshi Health ($200 million) and Headlight (Clinics/Outpatient Services) ($107 million).

How Galileo (Clinics/Outpatient Services)'s valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Galileo (Clinics/Outpatient Services), the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Galileo (Clinics/Outpatient Services)

What is Galileo (Clinics/Outpatient Services) worth?
Galileo (Clinics/Outpatient Services) is valued at $361.5M as of Oct 2026. Valued at $361.5M at its later-stage round, Jun 2025. Nothing has traded since.
How much has Galileo (Clinics/Outpatient Services) raised?
Galileo (Clinics/Outpatient Services) has raised $209.9M in total funding across 1 recorded rounds.
When did Galileo (Clinics/Outpatient Services) last raise?
Galileo (Clinics/Outpatient Services) last raised in Dec 2022 (Later Stage VC (Series D)), raising $60.0M.